NCT06598813Completed
Pediatric Headche Assessment Using HIT 6
Pediatric Headche Assessment Comparing PedMidas and HIT 6 Questionnaires
Source: ClinicalTrials.gov · Last updated 19 Sept 2024
Brief summary (registry, in English)
The study is a prospective cohort study. The study population will include 100 children aged 6-18 years suffering from headaches who visited the Pediatric Neurology Clinic at Bnai Zion Medical Center and completed both the PED-MIDAS and HIT-6 questionnaires, starting from November 2022 until the end of the study period. Data will be collected from medical records and from the two questionnaires completed by the children during their clinic visit.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 12 Sept 2024
- Start date
- 1 Dec 2022
- Primary completion date
- 1 Aug 2024
- Lead sponsor
- Bnai Zion Medical Center
- Diseases
- Migraine
- NCT number
- NCT06598813
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Dec 2022 to the primary completion date, 1 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Children with shoreter headaches.
- Children who are not able to fill the questionnaire
Who the study is looking for
- Chldern age 6-18 years with headache for at least 3 months.
- Children able to fill the questionnaire
Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bnai Zion Medical Cemter Coordinator of this site? Confirm its status | Haif | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.